A small piece of plastic that Centura Health has rolled out to all of its Colorado hospitals is expected to not only make the patient experience better but improve the safety of patients and staff.
The PIVO is a device manufactured by San Francisco-based Velano Vascular. It’s a needle-free, single-use device that connects to a patient’s intravenous line.
Vascular access technology pioneer Velano Vascular today announced that it has been named the Frost & Sullivan 2019 North American Product Leadership Award award recipient for its transformative needle-free blood draw technology. Sowmya Rajagopalan, Healthcare Research Director, applauds PIVO by saying, "clinically relevant laboratory results—confirming PIVO-drawn blood can inform clinical decision-making—as well as an enhanced patient experience is driving rapid market adoption. Early adopter Intermountain Healthcare was the first health system in the US to deploy PIVO system-wide as a
standard of care".
Centura Health, the region’s health care leader, went live across 17 hospitals in offering needle-free blood draws for inpatients using the PIVO™ device from Velano Vascular. “This new technology is changing the face of how patients experience hospital care,” says Dawn Bloemen, Centura Health’s Emerging Technology Analyst. Blood draws are such a common component of a hospital stay, the associated trauma to patients has largely been overlooked – and while the results inform 70% of all clinical decisions, there has been little innovation in this procedure or related technologies in decades.
Centura Health’s St. Catherine Hospital in Garden City and Bob Wilson Memorial Hospital in Ulysses recently began offering needle-free blood draws for inpatients, becoming the first health system in Kansas and Colorado to offer the technology.
Instead of needles, the draws are now being carried out with the PIVO™ device from Velano Vascular.
Todd Dunn is the director of innovation for Intermountain Healthcare and leader of the Healthcare Transformation Lab, where he oversees the Salt Lake City-based system's wide variety of new and ongoing innovation projects.
One such innovation — and one that will "continue to excite [Mr. Dunn] for a very long time" — is a collaboration with Velano Vascular, an early-stage company developing needle-free blood draws. Since launching the partnership in April, Intermountain has performed more than 400,000 needle-free blood draws and received countless notes of gratitude from patients, parents and phlebotomists.
By Alan Manning & Eric M. Stone | February 7, 2019 Congratulations, you’ve cracked the code on patient-centric innovation and experience. Your patients have never been happier or expressed greater levels of satisfaction with your healthcare delivery. From room amenities to online cost estimates to mobile scheduling using the latest newfangled apps, they are pleased as punch. But now that the pleasantries are behind us, let’s get serious. How do [...]
Named a 2019 Top Ten Most Innovative Company in Biotech by Fast Company, Velano will deploy new funds to meet rising demand for its transformative vascular access solutions San Francisco, Calif. – May 8, 2019 – Vascular access technology pioneer Velano Vascular today announced that it has secured $10 million as the initial tranche of a growth financing to fuel commercialization and the launch of additional novel vascular access [...]
By Jessica Cohen March 23, 2019 It’s not uncommon for medical staff to wake patients in the early hours of the morning to prick them for a blood draw. It’s a reality that Centura Health is trying to change. “What a rude way to wake up,” said Rhonda Ward, chief nursing officer for Centura’s south Denver group. “A bright light and a needlestick.” To tackle this problem, the Centennial, Colo.-based [...]